Clinical Trial Update: Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compares oral atogepant with oral topiramate in adults with migraine to assess adverse events. The study is currently active but not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Qulipta (atogepant) (atogepant)
• Topamax (Topiramate)

Snippet

Sponsor: AbbVie | Conditions: Migraine | Phase 3 | Status: ACTIVE_NOT_RECRUITING